Harald Labischinski
Keine laufenden Positionen mehr
Profil
Harald Labischinski held positions as a Director at Vivoryon Therapeutics NV, a Principal at Bayer AG, President at Combinature BioPharm AG in 2008, and Chief Scientific Officer at MerLion Pharmaceuticals Pte Ltd.
from 2006 to 2009.
Ehemalige bekannte Positionen von Harald Labischinski
| Unternehmen | Position | Ende |
|---|---|---|
Combinature BioPharm AG
 Combinature BioPharm AG Miscellaneous Commercial ServicesCommercial Services Combinature Biopharm AG discovers and develops drugs. It provides natural compound based clinical development candidates, particularly in the areas of infectious diseases and oncology. It applies its technologies to make improved versions of known natural product pharmaceuticals and to advance such improved drug candidates into pre-clinical and clinical trials. The company was founded in 2000 and is headquartered in Berlin, Germany. | Präsident | 27.08.2008 |
| VIVORYON THERAPEUTICS N.V. | Direktor/Vorstandsmitglied | - |
| BAYER AG | Corporate Officer/Principal | - |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BAYER AG | Health Technology |
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
Combinature BioPharm AG
Combinature BioPharm AG Miscellaneous Commercial ServicesCommercial Services Combinature Biopharm AG discovers and develops drugs. It provides natural compound based clinical development candidates, particularly in the areas of infectious diseases and oncology. It applies its technologies to make improved versions of known natural product pharmaceuticals and to advance such improved drug candidates into pre-clinical and clinical trials. The company was founded in 2000 and is headquartered in Berlin, Germany. | Commercial Services |
